U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Sclerosis of skull base

MedGen UID:
377095
Concept ID:
C1851714
Finding
Synonyms: Hyperostosis of skull base; Marked sclerosis of skull base; Sclerosis of the cranial base; Sclerosis of the skull base; Sclerotic skull base; Skull base sclerosis
 
HPO: HP:0002694

Definition

Increased bone density of the skull base without significant changes in bony contour. [from HPO]

Conditions with this feature

Diaphyseal dysplasia
MedGen UID:
4268
Concept ID:
C0011989
Finding
Camurati-Engelmann disease (CED) is characterized by hyperostosis of the long bones and the skull, proximal muscle weakness, limb pain, a wide-based, waddling gait, and joint contractures. Facial features such as macrocephaly, frontal bossing, enlargement of the mandible, proptosis, and cranial nerve impingement resulting in facial palsy are seen in severely affected individuals later in life.
Schinzel-Giedion syndrome
MedGen UID:
120517
Concept ID:
C0265227
Disease or Syndrome
Schinzel-Giedion syndrome is a highly recognizable syndrome characterized by severe mental retardation, distinctive facial features, and multiple congenital malformations including skeletal abnormalities, genitourinary and renal malformations, and cardiac defects, as well as a higher-than-normal prevalence of tumors, notably neuroepithelial neoplasia (summary by Hoischen et al., 2010).
Dysosteosclerosis
MedGen UID:
98150
Concept ID:
C0432262
Disease or Syndrome
A rare genetic primary bone dysplasia disease characterized by progressive osteosclerosis and platyspondyly.
Osteopathia striata with cranial sclerosis
MedGen UID:
96590
Concept ID:
C0432268
Disease or Syndrome
Most females with osteopathia striata with cranial sclerosis (OS-CS) present with macrocephaly and characteristic facial features (frontal bossing, hypertelorism, epicanthal folds, depressed nasal bridge, and prominent jaw). Approximately half have associated features including orofacial clefting and hearing loss, and a minority have some degree of developmental delay (usually mild). Radiographic findings of cranial sclerosis, sclerosis of long bones, and metaphyseal striations (in combination with macrocephaly) can be considered pathognomonic. Males can present with a mild or severe phenotype. Mildly affected males have clinical features similar to affected females, including macrocephaly, characteristic facial features, orofacial clefting, hearing loss, and mild-to-moderate learning delays. Mildly affected males are more likely than females to have congenital or musculoskeletal anomalies. Radiographic findings include cranial sclerosis and sclerosis of the long bones; Metaphyseal striations are more common in males who are mosaic for an AMER1 pathogenic variant. The severe phenotype manifests in males as a multiple-malformation syndrome, lethal in mid-to-late gestation, or in the neonatal period. Congenital malformations include skeletal defects (e.g., polysyndactyly, absent or hypoplastic fibulae), congenital heart disease, and brain, genitourinary, and gastrointestinal anomalies. Macrocephaly is not always present and longitudinal metaphyseal striations have not been observed in severely affected males, except for those who are mosaic for the AMER1 pathogenic variant.
Spondylometaphyseal dysplasia, Golden type
MedGen UID:
208672
Concept ID:
C0796172
Disease or Syndrome
A rare primary bone dysplasia disorder with characteristics of severe short stature, coarse facies, thoracolumbar kyphoscoliosis and enlarged joints with contractures. Psychomotor delay and intellectual disability may also be associated. Radiographic features include flat vertebral bodies, lacy ossification of the metaphyses of long bones and iliac crests, and marked sclerosis of the skull base.
Spondyloenchondrodysplasia with immune dysregulation
MedGen UID:
375009
Concept ID:
C1842763
Disease or Syndrome
Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) is an immunoosseous dysplasia combining the typical metaphyseal and vertebral bone lesions of spondyloenchondrodysplasia (SPENCD) with immune dysfunction and neurologic involvement. The skeletal dysplasia is characterized by radiolucent and irregular spondylar and metaphyseal lesions that represent islands of chondroid tissue within bone. The vertebral bodies show dorsally accentuated platyspondyly with disturbance of ossification. Clinical abnormalities such as short stature, rhizomelic micromelia, increased lumbar lordosis, barrel chest, facial anomalies, and clumsy movements may be present (Menger et al., 1989). Central nervous system involvement includes spasticity, mental retardation, and cerebral calcifications, and immune dysregulation ranges from autoimmunity to immunodeficiency. Neurologic and autoimmune manifestations have been observed in different combinations within a single family, suggesting that this disorder may be defined by specific radiographic features but has remarkably pleiotropic manifestations (Renella et al., 2006). Briggs et al. (2016) also noted variability in skeletal, neurologic, and immune phenotypes, which was sometimes marked between members of the same family. Classification of the Enchondromatoses In their classification of the enchondromatoses, Spranger et al. (1978) called Ollier disease and Maffucci syndrome types I and II enchondromatosis, respectively; metachondromatosis (156250), type III; and spondyloenchondrodysplasia (SPENCD), also called spondyloenchondromatosis, type IV; enchondromatosis with irregular vertebral lesions, type V; and generalized enchondromatosis, type VI. Halal and Azouz (1991) added 3 tentative categories to the 6 in the classification of Spranger et al. (1978). Pansuriya et al. (2010) suggested a new classification of enchondromatosis (multiple enchondromas).
Oto-palato-digital syndrome, type II
MedGen UID:
337064
Concept ID:
C1844696
Disease or Syndrome
The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.
Lateral meningocele syndrome
MedGen UID:
342070
Concept ID:
C1851710
Disease or Syndrome
NOTCH3-related lateral meningocele syndrome (LMS) is characterized by multiple lateral spinal meningoceles (protrusions of the arachnoid and dura through spinal foramina), distinctive facial features, joint hyperextensibility, hypotonia, and skeletal, cardiac, and urogenital anomalies. Neurologic sequelæ of the meningoceles depend on size and location and can include neurogenic bladder, paresthesia, back pain, and/or paraparesis. Other neurologic findings can include Chiari I malformation, syringomyelia, and rarely, hydrocephalus. Additional findings of LMS include developmental delay, mixed or conductive hearing loss, and cleft palate. Skeletal abnormalities may include scoliosis, vertebral fusion, scalloping of vertebrae, and wormian bones. Infants may demonstrate feeding difficulties with poor weight gain.
Craniometaphyseal dysplasia, autosomal dominant
MedGen UID:
338945
Concept ID:
C1852502
Disease or Syndrome
Autosomal dominant craniometaphyseal dysplasia (designated AD-CMD in this review) is characterized by progressive diffuse hyperostosis of cranial bones evident clinically as wide nasal bridge, paranasal bossing, widely spaced eyes with an increase in bizygomatic width, and prominent mandible. Development of dentition may be delayed and teeth may fail to erupt as a result of hyperostosis and sclerosis of alveolar bone. Progressive thickening of craniofacial bones continues throughout life, often resulting in narrowing of the cranial foramina, including the foramen magnum. If untreated, compression of cranial nerves can lead to disabling conditions such as facial palsy, blindness, or deafness (conductive and/or sensorineural hearing loss). In individuals with typical uncomplicated AD-CMD life expectancy is normal; in those with severe AD-CMD life expectancy can be reduced as a result of compression of the foramen magnum.
Greenberg dysplasia
MedGen UID:
418969
Concept ID:
C2931048
Disease or Syndrome
Greenberg dysplasia (GRBGD), also known as hydrops-ectopic calcification-moth-eaten (HEM) skeletal dysplasia, is a rare autosomal recessive osteochondrodysplasia characterized by gross fetal hydrops, severe shortening of all long bones with a moth-eaten radiographic appearance, platyspondyly, disorganization of chondroosseous calcification, and ectopic ossification centers. It is lethal in utero. Patient fibroblasts show increased levels of cholesta-8,14-dien-3-beta-ol, suggesting a defect of sterol metabolism (summary by Konstantinidou et al., 2008). Herman (2003) reviewed the cholesterol biosynthetic pathway and 6 disorders involving enzyme defects in postsqualene cholesterol biosynthesis: Smith-Lemli-Opitz syndrome (SLOS; 270400), desmosterolosis (602398), X-linked dominant chondrodysplasia punctata (CDPX2; 302960), CHILD syndrome (308050), lathosterolosis (607330), and HEM skeletal dysplasia.
Paget disease of bone 2, early-onset
MedGen UID:
899166
Concept ID:
C4085251
Disease or Syndrome
Paget disease (PDB) is a metabolic bone disease characterized by focal abnormalities of increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Bone lesions in this disorder show evidence of increased osteoclastic bone resorption and disorganized bone structure. See reviews by Ralston et al. (2008) and Ralston and Albagha (2014). For a discussion of genetic heterogeneity of Paget disease of bone, see 167250.
Craniometadiaphyseal dysplasia wormian bone type
MedGen UID:
1382152
Concept ID:
C4510809
Disease or Syndrome
Craniometadiaphyseal dysplasia (CRMDD) is characterized clinically by macrocephaly with frontal prominence, dental hypoplasia, and increased bone fragility. Diagnostic radiologic features include thin bones in the superior part of calvaria with prominent wormian bones, diaphyseal widening of the long tubular bones in early childhood with wide undermineralized metaphyses in older individuals, widened ribs and clavicles, and broadening of short tubular bones with increased transparency and thin cortices (summary by Dhar et al., 2010).
Spondyloepimetaphyseal dysplasia, Krakow type
MedGen UID:
1648323
Concept ID:
C4748455
Disease or Syndrome
Krakow-type spondyloepimetaphyseal dysplasia is characterized by severe skeletal dysplasia, severe immunodeficiency, and developmental delay (Csukasi et al., 2018).
Craniotubular dysplasia, Ikegawa type
MedGen UID:
1806238
Concept ID:
C5575335
Disease or Syndrome
Craniotubular dysplasia, Ikegawa type (CTDI) is characterized by childhood-onset short stature in association with macrocephaly, dolichocephaly, or prominent forehead. Radiography shows hyperostosis of the calvaria and skull base, with metadiaphyseal undermodeling of the long tubular bones and mild shortening and diaphyseal broadening of the short tubular bones. Affected individuals experience progressive vision loss in the first decade of life due to optic nerve compression, and deafness may develop in the second decade of life (Guo et al., 2021).

Professional guidelines

PubMed

Jenkins TM, Alix JJ, Kandler RH, Shaw PJ, McDermott CJ
Muscle Nerve 2016 Sep;54(3):378-85. Epub 2016 Jun 9 doi: 10.1002/mus.25062. PMID: 26821620

Recent clinical studies

Etiology

GBD 2021 Tobacco Forecasting Collaborators
Lancet Public Health 2024 Oct;9(10):e729-e744. doi: 10.1016/S2468-2667(24)00166-X. PMID: 39366729Free PMC Article
GBD 2021 Stroke Risk Factor Collaborators
Lancet Neurol 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7. PMID: 39304265
Liu J, Hou S, Zhang Q, Qi Y, Zhang S, Wang Z
ORL J Otorhinolaryngol Relat Spec 2022;84(6):464-472. Epub 2022 Jul 12 doi: 10.1159/000525260. PMID: 35820402
Akbari Dilmaghani N, Hussen BM, Nateghinia S, Taheri M, Ghafouri-Fard S
Metab Brain Dis 2021 Jun;36(5):737-749. Epub 2021 Feb 19 doi: 10.1007/s11011-021-00697-5. PMID: 33604874
Jenkins TM, Alix JJ, Kandler RH, Shaw PJ, McDermott CJ
Muscle Nerve 2016 Sep;54(3):378-85. Epub 2016 Jun 9 doi: 10.1002/mus.25062. PMID: 26821620

Diagnosis

Ghafouri-Fard S, Poulet C, Malaise M, Abak A, Mahmud Hussen B, Taheriazam A, Taheri M, Hallajnejad M
Front Immunol 2021;12:773171. Epub 2021 Nov 29 doi: 10.3389/fimmu.2021.773171. PMID: 34912342Free PMC Article
Shaikh AG, Manto M
Cerebellum 2019 Aug;18(4):673-675. doi: 10.1007/s12311-019-01032-6. PMID: 31028519
Ullah A, Pervez N, Khan SR, Ishfaq M, Liaqat S
J Coll Physicians Surg Pak 2015 Oct;25 Suppl 2:S127-9. doi: 10.2015/JCPSP.S127S129. PMID: 26522199
Heckmann JG, Lang CJG
Adv Otorhinolaryngol 2006;63:255-264. doi: 10.1159/000093764. PMID: 16733343
Slamovits TL, Gardner TA
Ophthalmology 1989 Apr;96(4):555-68. doi: 10.1016/s0161-6420(89)32877-6. PMID: 2657540

Therapy

Simani L, Roozbeh M, Shojaei M, Ramezani M, Roozbeh M, Gharehgozli K, Rostami M
Mult Scler Relat Disord 2022 Dec;68:104392. Epub 2022 Nov 2 doi: 10.1016/j.msard.2022.104392. PMID: 36544322
Ullah A, Pervez N, Khan SR, Ishfaq M, Liaqat S
J Coll Physicians Surg Pak 2015 Oct;25 Suppl 2:S127-9. doi: 10.2015/JCPSP.S127S129. PMID: 26522199
Heckmann JG, Lang CJG
Adv Otorhinolaryngol 2006;63:255-264. doi: 10.1159/000093764. PMID: 16733343
Sung MW, Kim KH, Lee CH, Moh JH, Kim WH, Han MH
Laryngoscope 1997 Dec;107(12 Pt 1):1651-5. doi: 10.1097/00005537-199712000-00014. PMID: 9396681
Tronnier VM, Wirtz CR, Knauth M, Bonsanto MM, Hassfeld S, Albert FK, Kunze S
Stereotact Funct Neurosurg 1996;66(1-3):65-8. doi: 10.1159/000099669. PMID: 8938934

Prognosis

GBD 2021 Stroke Risk Factor Collaborators
Lancet Neurol 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7. PMID: 39304265
Ghafouri-Fard S, Poulet C, Malaise M, Abak A, Mahmud Hussen B, Taheriazam A, Taheri M, Hallajnejad M
Front Immunol 2021;12:773171. Epub 2021 Nov 29 doi: 10.3389/fimmu.2021.773171. PMID: 34912342Free PMC Article
Fassett DR, Couldwell WT
Neurosurg Focus 2004 Apr 15;16(4):E8. PMID: 15191337
Majoie CB, Verbeeten B Jr, Dol JA, Peeters FL
Radiographics 1995 Jul;15(4):795-811. doi: 10.1148/radiographics.15.4.7569130. PMID: 7569130
Slamovits TL, Gardner TA
Ophthalmology 1989 Apr;96(4):555-68. doi: 10.1016/s0161-6420(89)32877-6. PMID: 2657540

Clinical prediction guides

Ramezani M, Ryan F, Sahraian MA, Simani L
Mult Scler Relat Disord 2022 Jan;57:103336. Epub 2021 Oct 31 doi: 10.1016/j.msard.2021.103336. PMID: 35158464
Ladd LM, Imel EA, Niziolek PJ, Liu Z, Warden SJ, Liang Y, Econs MJ
Skeletal Radiol 2021 May;50(5):903-913. Epub 2020 Oct 3 doi: 10.1007/s00256-020-03625-3. PMID: 33009917Free PMC Article
Xie CM, Liu XW, Li H, Zhang R, Mo YX, Li JP, Geng ZJ, Zheng L, Lv YC, Wu PH
J Otolaryngol Head Neck Surg 2011 Aug;40(4):300-10. PMID: 21777548
Curé JK, Key LL, Goltra DD, VanTassel P
AJNR Am J Neuroradiol 2000 Jun-Jul;21(6):1110-5. PMID: 10871023Free PMC Article
Elster AD, Theros EG, Key LL, Chen MY
Radiology 1992 Apr;183(1):137-44. doi: 10.1148/radiology.183.1.1549660. PMID: 1549660

Recent systematic reviews

Zhou DJ, Woodson-Smith S, Emmert BE, Kornspun A, Larocque J, Kulick-Soper CV, Qiu MK, Ellis CA, Gugger JJ, Conrad EC, Waldman G, Ganguly T, Sinha SR, Davis KA, Stein JM, Liu GT, Gelfand M, Raghupathi R
Epilepsy Behav 2024 Sep;158:109928. Epub 2024 Jul 2 doi: 10.1016/j.yebeh.2024.109928. PMID: 38959747
Yaghoobpoor S, Fathi M, Vakili K, Sayehmiri F, Alipour M, Miriran ZS, Ghayyem H, Tutunchian Z, Hajibeygi R, Batool Z, Mirzadeh M, Aghazadeh MH, Hajiesmaeili M
PLoS One 2024;19(4):e0297091. Epub 2024 Apr 17 doi: 10.1371/journal.pone.0297091. PMID: 38630771Free PMC Article
Baba A, Matsushima S, Kessoku H, Omura K, Kurokawa R, Fukasawa N, Takeshita Y, Yamauchi H, Ogino N, Kayama R, Uchihara K, Yoshimatsu L, Ojiri H
Neuroradiology 2024 Feb;66(2):249-259. Epub 2023 Dec 16 doi: 10.1007/s00234-023-03254-2. PMID: 38103083
Ramezani M, Ryan F, Sahraian MA, Simani L
Mult Scler Relat Disord 2022 Jan;57:103336. Epub 2021 Oct 31 doi: 10.1016/j.msard.2021.103336. PMID: 35158464
Zicari AM, Tarani L, Perotti D, Papetti L, Nicita F, Liberati N, Spalice A, Salvatori G, Guaraldi F, Duse M
Ital J Pediatr 2012 Jun 20;38:27. doi: 10.1186/1824-7288-38-27. PMID: 22716240Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...